Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|November 22, 2011
Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profileMatthew Anaka, Claudia Freyer, Craig Gedye, et al.Oncoimmunology|January 23, 2015
The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populationsLaura J Vella, Miles C Andrews, Anupama Pasam, et al.Scientific Reports|June 23, 2015
Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutationsSimon Chang-Hao Tsao, Jonathan Weiss, Christopher Hudson, et al.Analytical Chemistry|October 12, 2022
SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade TherapyJunrong Li, Alain Wuethrich, Zhen Zhang, et al.Journal for Immunotherapy of Cancer|February 18, 2016
Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanomaKatherine Woods, Ashley J Knights, Matthew Anaka, et al.Oncotarget|May 6, 2015
Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasionPrashanth Prithviraj, Matthew Anaka, Sonja J McKeown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic MelanomaMiles C Andrews, Natalie Turner, Janis Boyd, et al.STAR Protocols|January 12, 2023
Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistryLuke T Quigley, Lokman Pang, Elnaz Tavancheh, et al.Molecular Cancer|June 30, 2017
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activationCandani S A Tutuka, Miles C Andrews, John M Mariadason, et al.Molecular Cancer|November 18, 2016
Systems analysis identifies miR-29b regulation of invasiveness in melanomaMiles C Andrews, Joseph Cursons, Daniel G Hurley, et al.Pageof 8